Lucira Health, Inc. — Form D/A
Lucira Health, Inc. of EMERYVILLE, CA, a company, filed a Form D amendment with the SEC on 2020-01-16. The offering totals $32.5M, of which $32.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-01-16
- Form: D/A
- Accession: 0001652724-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $32.5M
- Amount sold: $32.5M
- Investors: 30
- Date of first sale: 2019-03-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-345969
Issuer
- Name: Lucira Health, Inc.
- CIK: 0001652724
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1412 62ND STREET, EMERYVILLE, CA, 94608
- Phone: (814) 574-1546
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Justin T Butler | Director | Emeryville, CA |
| Erik T Engelson | Director | Fremont, CA |
| Debkishore R Mitra | Director | Emeryville, CA |
| Steve R Tablak | Director | Emeryville, CA |
| John R Waldeisen | Director | Emeryville, CA |
| Tuff T Yen | Director | Emeryville, CA |
| Erik T Engelson | Executive Officer | Fremont, CA |
Other filings by this issuer (1)
More